Form D · Pharmaceuticals

Slate Pharmaceuticals, Inc.

Durham, NC · CIK 0001469231

Offering snapshot reported Sep 27, 2010 · SEC filing

Reported sold
$1.99M
Offering amount: $2M
Investors reported
40
Form D · investor count
Minimum accepted
$1
Reported outside-investor minimum
First sale
Sep 13, 2010
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 27, 2010Initial$1,990,000No comparison40SEC filing
Jan 29, 2010Amendment$2,787,000$170,050vs Nov 19, 200933SEC filing
Nov 19, 2009Amendment$2,616,950$1,646,320vs Aug 18, 200933SEC filing
Aug 18, 2009Initial$970,630No comparison13SEC filing

Offering details

Securities
Debt, Option to acquire, Security to be acquired
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-148195
N/A

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
N/ANone

Source: Form D, filed Sep 27, 2010. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Kenneth Ramsey Couch Director
William Robert Dahl Director
Richard De Schutter Director
Douglas Eckert Director
Michael Ford Director
Trygve Mikkelsen Director
Robert Stanley Whitehead Director, Executive
Anthony Wild Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
318 Blackwell Street Suite 240
Durham, NC, 27701